Pasteuria Bioscience
Founded Year
2003Stage
Acquired | AcquiredTotal Raised
$10.95MValuation
$0000About Pasteuria Bioscience
Pasteuria Bioscience is an agricultural biotechnology company formed to address a unmet pest-control problem: plant-parasitic nematodes. Our technology aims to allow the in-vitro growth and sporulation of Pasteuria penetrans, a naturally-occurring nematode pathogen, for nematode control in crops ranging from high-value ornamentals to agronomic staples. In September 2012, Pasteuria Bioscience was acquired by Syngenta. The valuation of Pasteuria Bioscience was $113 million. Other terms of the deal were not released.
Missing: Pasteuria Bioscience's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pasteuria Bioscience's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Pasteuria Bioscience
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pasteuria Bioscience is included in 1 Expert Collection, including Agriculture Technology (Agtech).
Agriculture Technology (Agtech)
1,921 items
Companies that are using technology to make farms more efficient.
Pasteuria Bioscience Patents
Pasteuria Bioscience has filed 4 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/16/2014 | 7/7/2015 | Tylenchida, Agricultural pest nematodes, Parasitic nematodes of mammals, Spirurida, Parasitic nematodes | Grant |
Application Date | 6/16/2014 |
|---|---|
Grant Date | 7/7/2015 |
Title | |
Related Topics | Tylenchida, Agricultural pest nematodes, Parasitic nematodes of mammals, Spirurida, Parasitic nematodes |
Status | Grant |
Latest Pasteuria Bioscience News
Nov 30, 2016
Pasteuria Bioscience, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 15:34 EST 30 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Pasteuria Bioscience, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pasteuria Bioscience , Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Pasteuria Bioscience, Inc. since January 2007. Key Findings Provides intelligence on Pasteuria Bioscience, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Pasteuria Bioscience, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Pasteuria Bioscience, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Pasteuria Bioscience, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
Pasteuria Bioscience Frequently Asked Questions (FAQ)
When was Pasteuria Bioscience founded?
Pasteuria Bioscience was founded in 2003.
Where is Pasteuria Bioscience's headquarters?
Pasteuria Bioscience's headquarters is located at 12085 Research Drive, Alachua.
What is Pasteuria Bioscience's latest funding round?
Pasteuria Bioscience's latest funding round is Acquired.
How much did Pasteuria Bioscience raise?
Pasteuria Bioscience raised a total of $10.95M.
Who are the investors of Pasteuria Bioscience?
Investors of Pasteuria Bioscience include Syngenta, Advantage Capital, Florida Gulfshore Capital, Gordon River Capital, EQT Life Sciences and 3 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.